2022
DOI: 10.3389/fpsyt.2022.863734
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Markers in Substance Use and Mood Disorders: A Neuroimaging Perspective

Abstract: Chronic exposure to addictive drugs in substance use disorders and stressors in mood disorders render the brain more vulnerable to inflammation. Inflammation in the brain, or neuroinflammation, is characterized by gliosis, microglial activation, and sustained release of cytokines, chemokines, and pro-inflammatory factors compromising the permeability of the blood-brain barrier. There is increased curiosity in understanding how substance misuse and/or repeated stress exposure affect inflammation and contribute … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(23 citation statements)
references
References 181 publications
1
13
0
Order By: Relevance
“…It is involved in the regulation of inflammatory responses via its interaction with L-selectin (Ivetic et al, 2019). These observations support the notion that METH use disorder might involve the activation of neuroinflammatory cascades in the brain (Sekine et al, 2008;Agarwal et al, 2022), with METH-induced neuroinflammation being responsible, in part, for the learning and memory deficits reported in patients with MUD (Moszczynska and Callan, 2017;Paulus and Stewart, 2020). Neuroinflammation-induced changes in the basic processes that regulate synaptic plasticity (Cornell et al, 2022;Mancini et al, 2022) might also promote the perpetuation of substance use disorders.…”
Section: Discussionsupporting
confidence: 72%
“…It is involved in the regulation of inflammatory responses via its interaction with L-selectin (Ivetic et al, 2019). These observations support the notion that METH use disorder might involve the activation of neuroinflammatory cascades in the brain (Sekine et al, 2008;Agarwal et al, 2022), with METH-induced neuroinflammation being responsible, in part, for the learning and memory deficits reported in patients with MUD (Moszczynska and Callan, 2017;Paulus and Stewart, 2020). Neuroinflammation-induced changes in the basic processes that regulate synaptic plasticity (Cornell et al, 2022;Mancini et al, 2022) might also promote the perpetuation of substance use disorders.…”
Section: Discussionsupporting
confidence: 72%
“…During early abstinence, many subjects present a prodrome of cognitive and behavioural changes that are strikingly similar to those of sickness behaviour syndrome due to increased levels of pro-inflammatory cytokines (Dantzer et al ., 2008). Therefore, considering drug abuse from a chronic stress perspective, cytokine-related damage observed in chronic stress, neuroinflammation, and drug abuse may lead to sickness behaviour syndrome-like symptoms and open the door for relapse (Agarwal et al ., 2022). The elevated inflammatory profile may thus influence peripheral leukocytes as well as brain cells involved with changes in behaviour and related symptomatology in CUD.…”
Section: Discussionmentioning
confidence: 99%
“…Brain atrophy, commonly seen with chronic alcohol consumption, likely results from hyperglutamatergic activity and neuroinflammation 110111. It is important to recognize and inform your patient that functional and structural recovery occurs with abstinence, particularly in the frontal cortex 112113…”
Section: Neurobiology In Alcohol Use Disordersmentioning
confidence: 99%